Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype

被引:19
|
作者
Slattery, Martha L. [1 ]
Lee, Frances Y. [2 ]
Pellatt, Andrew J. [2 ]
Mullany, Lila E. [1 ]
Stevens, John R. [3 ]
Samowitz, Wade S. [4 ]
Wolff, Roger K. [1 ]
Herrick, Jennifer S. [1 ]
机构
[1] Univ Utah, Dept Med, 383 Colorow, Salt Lake City, UT 84108 USA
[2] Tulane Med Sch, New Orleans, LA USA
[3] Utah State Univ, Dept Math & Stat, Logan, UT 84322 USA
[4] Univ Utah, Dept Pathol, Salt Lake City, UT USA
关键词
ISLAND METHYLATOR PHENOTYPE; KI-RAS MUTATIONS; POPULATION-BASED SAMPLE; LIFE-STYLE FACTORS; COLON-CANCER; MICROSATELLITE INSTABILITY; GENE-EXPRESSION; DIETARY-INTAKE; PATIENT SURVIVAL; PATHWAY ANALYSIS;
D O I
10.1038/modpathol.2017.38
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
We have previously shown that commonly expressed miRNAs influenced tumor molecular phenotype in colorectal cancer. We hypothesize that infrequently expressed miRNAs, when showing higher levels of expression, help to define tumor molecular phenotype. In this study, we examine 304 miRNAs expressed in at least 30 individuals, but in <50% of the population and with a mean level of expression above 1.0 relative florescent unit. We examine associations in 1893 individuals who have the tumor molecular phenotype data as well as miRNA expression levels for both carcinoma and normal colorectal tissue. We compare miRNAs uniquely associated with tumor molecular phenotype to the RNAseq data to identify genes associated with these miRNAs. This information is used to further identify unique pathways associated with tumor molecular phenotypes of TP53-mutated, KRAS-mutated, CpG island methylator phenotype and microsatellite instability tumors. Thirty-seven miRNAs were uniquely associated with TP53-mutated tumors; 30 of these miRNAs had higher level of expression in TP53-mutated tumors, while seven had lower levels of expression. Of the 34 miRNAs associated with CpG island methylator phenotype-high tumors, 16 were more likely to have a CpG island methylator phenotype-high tumor and 19 were less likely to be CpG island methylator phenotype-high. For microsatellite instability, 13 of the 22 infrequently expressed miRNAs were significantly less likely to be expressed in microsatellite unstable tumors. KRAS-mutated tumors were not associated with any miRNAs after adjustment for multiple comparisons. Of the dysregulated miRNAs, 17 were more likely to be TP53-mutated tumors while simultaneously being less likely to be CpG island methylator phenotype-high and/or microsatellite instability tumors. Genes regulated by these miRNAs were involved in numerous functions and pathways that influence cancer risk and progression. In summary, some infrequently expressed miRNAs, when expressed at higher levels, appear to have significant biological meaning in terms of tumor molecular phenotype and gene expression profiles.
引用
收藏
页码:1152 / 1169
页数:18
相关论文
共 50 条
  • [1] Infrequently expressed miRNAs in colorectal cancer tissue and tumor molecular phenotype (vol 30, pg 1152, 2017)
    Slattery, Martha L.
    Lee, Frances Y.
    Pellatt, Andrew J.
    Mullany, Lila E.
    Stevens, John R.
    Samowitz, Wade S.
    Wolff, Roger K.
    Herrick, Jennifer S.
    [J]. MODERN PATHOLOGY, 2018, 31 (01) : 209 - 209
  • [2] Infrequently expressed miRNAs influence survival after diagnosis with colorectal cancer
    Slattery, Martha L.
    Pellatt, Andrew J.
    Lee, Frances Y.
    Herrick, Jennifer S.
    Samowitz, Wade S.
    Stevens, John R.
    Wolff, Roger K.
    Mullany, Lila E.
    [J]. ONCOTARGET, 2017, 8 (48) : 83845 - 83859
  • [3] Relationship between circulating tumor DNA and molecular phenotype in colorectal cancer
    Ebi, Hiromichi
    [J]. CANCER SCIENCE, 2023, 114 : 1704 - 1704
  • [4] Molecular Profiling of Tumor Tissue in Mexican Patients with Colorectal Cancer
    Flores-Lopez, Beatriz Armida
    Ayala-Madrigal, Maria de la Luz
    Moreno-Ortiz, Jose Miguel
    Peregrina-Sandoval, Jorge
    Trujillo-Rojas, Miguel Angel
    Venegas-Rodriguez, Jose Luis
    Hernandez-Ramirez, Rosario
    Fernandez-Galindo, Martha Alejandra
    Gutierrez-Angulo, Melva
    [J]. CURRENT ISSUES IN MOLECULAR BIOLOGY, 2022, 44 (08) : 3770 - 3778
  • [5] INFLUENCE OF PREDIAGNOSTIC CIGARETTE SMOKING ON COLORECTAL CANCER SURVIVAL: OVERALL AND BY TUMOR MOLECULAR PHENOTYPE
    Zhu, Yun
    Wang, Peizhong P.
    Yang, Siao R.
    Savas, Sevtap
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 255 - 256
  • [6] THE COLORECTAL CANCER: BREAST CANCER PHENOTYPE AND POSSIBLE MOLECULAR EXPLANATIONS
    Nowakowska, D.
    Kluska, A.
    Konopka, B.
    Janiec-Jankowska, A.
    Rembiszewska, A.
    Kosakowska, E.
    [J]. ANNALS OF ONCOLOGY, 2010, 21 : 41 - 42
  • [7] Colorectal tumor molecular phenotype and miRNA: expression profiles and prognosis
    Slattery, Martha L.
    Herrick, Jennifer S.
    Mullany, Lila E.
    Wolff, Erica
    Hoffman, Michael D.
    Pellatt, Daniel F.
    Stevens, John R.
    Wolff, Roger K.
    [J]. MODERN PATHOLOGY, 2016, 29 (08) : 915 - 927
  • [8] Molecular Cancer Phenotype in Normal Prostate Tissue
    Schlomm, Thorsten
    Hellwinkel, Olaf J. C.
    Buness, Andreas
    Ruschhaupt, Markus
    Luebke, Andreas M.
    Chun, Felix K.
    Simon, Ronald
    Budaeus, Lars
    Erbersdobler, Andreas
    Graefen, Markus
    Huland, Hartwig
    Poustka, Annemarie
    Sueltmann, Holger
    [J]. EUROPEAN UROLOGY, 2009, 55 (04) : 885 - 891
  • [9] INVESTIGATING EXOSOMAL MIRNAS AND PROTEINS DERIVED FROM COLORECTAL TISSUE AND PLASMA IN THE PROGRESSION OF COLORECTAL CANCER
    Hellmers, L.
    Sheng, J.
    Guanzon, D.
    Maresh, G.
    Klinger, A.
    Green, H.
    Zhang, X.
    Gallo, C. Salomon
    Li, L.
    Margolin, D. A.
    [J]. DISEASES OF THE COLON & RECTUM, 2019, 62 (06) : E47 - E47
  • [10] Molecular mechanisms and clinical implications of miRNAs in drug resistance of colorectal cancer
    Duan, Lili
    Yang, Wanli
    Feng, Weibo
    Cao, Lu
    Wang, Xiaoqian
    Niu, Liaoran
    Li, Yiding
    Zhou, Wei
    Zhang, Yujie
    Liu, Jinqiang
    Zhang, Hongwei
    Zhao, Qingchuan
    Hong, Liu
    Fan, Daiming
    [J]. THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12